240 related articles for article (PubMed ID: 31656261)
1. Factors predicting endocrine late effects in childhood cancer survivors from a Japanese hospital.
Shimazaki S; Kazukawa I; Mori K; Kihara M; Minagawa M
Endocr J; 2020 Feb; 67(2):131-140. PubMed ID: 31656261
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes.
van Iersel L; Li Z; Srivastava DK; Brinkman TM; Bjornard KL; Wilson CL; Green DM; Merchant TE; Pui CH; Howell RM; Smith SA; Armstrong GT; Hudson MM; Robison LL; Ness KK; Gajjar A; Krull KR; Sklar CA; van Santen HM; Chemaitilly W
J Clin Endocrinol Metab; 2019 Dec; 104(12):6101-6115. PubMed ID: 31373627
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Small Adult Height in Childhood Cancer Survivors.
Demoor-Goldschmidt C; Allodji RS; Journy N; Rubino C; Zrafi WS; Debiche G; Llanas D; Veres C; Thomas-Teinturier C; Pacquement H; Vu-Bezin G; Fresneau B; Berchery D; Bolle S; Diallo I; Haddy N; de Vathaire F
J Clin Oncol; 2020 Jun; 38(16):1785-1796. PubMed ID: 32196392
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone deficiency and other endocrinopathies after childhood brain tumors: results from a close follow-up in a cohort of 242 patients.
Maciel J; Dias D; Cavaco D; Donato S; Pereira MC; Simões-Pereira J
J Endocrinol Invest; 2021 Nov; 44(11):2367-2374. PubMed ID: 33683662
[TBL] [Abstract][Full Text] [Related]
5. Endocrine outcome in long-term survivors of childhood brain tumors.
Shalitin S; Gal M; Goshen Y; Cohen I; Yaniv I; Phillip M
Horm Res Paediatr; 2011; 76(2):113-22. PubMed ID: 21691048
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study.
Clement SC; Schouten-van Meeteren AY; Boot AM; Claahsen-van der Grinten HL; Granzen B; Sen Han K; Janssens GO; Michiels EM; van Trotsenburg AS; Vandertop WP; van Vuurden DG; Kremer LC; Caron HN; van Santen HM
J Clin Oncol; 2016 Dec; 34(36):4362-4370. PubMed ID: 27998218
[TBL] [Abstract][Full Text] [Related]
7. Metabolic/endocrine disorders in survivors of childhood-onset and cranial radiotherapy- treated ALL/NHL: a meta-analysis.
Zhang D; Gu M
Reprod Biol Endocrinol; 2023 Oct; 21(1):91. PubMed ID: 37794442
[TBL] [Abstract][Full Text] [Related]
8. Endocrine health conditions in adult survivors of childhood cancer: the need for specialized adult-focused follow-up clinics.
Brignardello E; Felicetti F; Castiglione A; Chiabotto P; Corrias A; Fagioli F; Ciccone G; Boccuzzi G
Eur J Endocrinol; 2013 Mar; 168(3):465-72. PubMed ID: 23258270
[TBL] [Abstract][Full Text] [Related]
9. Late endocrine effects of childhood cancer.
Rose SR; Horne VE; Howell J; Lawson SA; Rutter MM; Trotman GE; Corathers SD
Nat Rev Endocrinol; 2016 Jun; 12(6):319-36. PubMed ID: 27032982
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation].
Niedzielska E; Wójcik D; Barg E; Pietras W; Sega-Pondel D; Doroszko A; Niedzielska M; Skarzyńska M; Chybicka A
Med Wieku Rozwoj; 2008; 12(3):761-6. PubMed ID: 19305027
[TBL] [Abstract][Full Text] [Related]
11. Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.
Chow EJ; Anderson L; Baker KS; Bhatia S; Guilcher GM; Huang JT; Pelletier W; Perkins JL; Rivard LS; Schechter T; Shah AJ; Wilson KD; Wong K; Grewal SS; Armenian SH; Meacham LR; Mulrooney DA; Castellino SM
Biol Blood Marrow Transplant; 2016 May; 22(5):782-95. PubMed ID: 26802323
[TBL] [Abstract][Full Text] [Related]
12. The outcome of allogeneic hematopoietic stem cell transplants without total body irradiation in pediatric patients with acute lymphoblastic leukemia: single centre experience.
Hamidieh A; Kargar M; Jahani M; Alimoghaddam K; Bahar B; Mousavi SA; Iravani M; Jalali A; Jalili M; Ghavamzadeh A
J Pediatr Hematol Oncol; 2012 Mar; 34(2):101-7. PubMed ID: 22367385
[TBL] [Abstract][Full Text] [Related]
13. Growth impairment and gonadal axis abnormalities are common in survivors of paediatric brain tumours.
Pietilä S; Mäkipernaa A; Koivisto AM; Lenko HL
Acta Paediatr; 2017 Oct; 106(10):1684-1693. PubMed ID: 28683157
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of intensified myeloablative conditioning regime without antithymocytic globulin (ATG) with myeloablative conditioning regime for single-unit unrelated umbilical cord blood transplantation in hematological malignancies].
Sun ZM; Liu HL; Wu Y; Geng LQ; Zheng CC; Tang BL; Zhu XY; Tong J; Wang XB; Ding KY; Wan X; Zhang L; Yao W; Zhang XH; Han YS; Yang HZ; Liu X; Zhu WW; Wu JS; Wang ZY
Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(28):2214-9. PubMed ID: 27480651
[TBL] [Abstract][Full Text] [Related]
15. The impact of severe late-effects after 12 Gy fractionated total body irradiation and allogeneic stem cell transplantation for childhood leukemia (1988-2010).
Freycon F; Casagranda L; Trombert-Paviot B
Pediatr Hematol Oncol; 2019 Mar; 36(2):86-102. PubMed ID: 30978121
[TBL] [Abstract][Full Text] [Related]
16. Second hematopoietic stem cell transplantation in pediatric patients: overall survival and long-term follow-up.
Shah AJ; Kapoor N; Weinberg KI; Crooks GM; Kohn DB; Lenarsky C; Kaufman F; Epport K; Wilson K; Parkman R
Biol Blood Marrow Transplant; 2002; 8(4):221-8. PubMed ID: 12014811
[TBL] [Abstract][Full Text] [Related]
17. Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hematological Malignancies.
Alousi AM; Brammer JE; Saliba RM; Andersson B; Popat U; Hosing C; Jones R; Shpall EJ; Khouri I; Qazilbash M; Nieto Y; Shah N; Ahmed S; Oran B; Al Atrash G; Ciurea S; Kebriaei P; Chen J; Rondon G; Champlin RE
Biol Blood Marrow Transplant; 2015 May; 21(5):906-12. PubMed ID: 25667989
[TBL] [Abstract][Full Text] [Related]
18. Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood.
Bakker B; Oostdijk W; Bresters D; Walenkamp MJ; Vossen JM; Wit JM
Bone Marrow Transplant; 2004 May; 33(10):1049-56. PubMed ID: 15048143
[TBL] [Abstract][Full Text] [Related]
19. Endocrine late effects in survivors of infantile acute lymphoblastic leukemia.
Akisada H; Hasegawa M; Ishihara T; Akisada N; Ochi S; Nogami K
Clin Pediatr Endocrinol; 2023; 32(2):90-97. PubMed ID: 37020698
[TBL] [Abstract][Full Text] [Related]
20. A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis.
Gooptu M; Kim HT; Ho VT; Alyea EP; Koreth J; Armand P; Ritz J; Nikiforow S; Glotzbecker BE; Nageshwar P; Soiffer RJ; Antin JH; Cutler CS
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1733-1740. PubMed ID: 29555313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
